in their concluding remarks the authors state that in addition to being effective in the morbid condition selected for trial , cotrimazine offers some advantages over similar combinations of tmp and other sulfonamides , both because of the intrinsic physicochemical and pharmacological properties of sdz and because of its lower dosage in this combination .
C0038760
sulfonamides
C0038675
sdz